1. Introduction

molecules

Molecules

1420-3049

MDPI

10.3390/molecules17044474

molecules-17-04474

Article

Antiangiogenic Polyketides from Peperomia dindygulensis Miq

Wang

Qi-Wei

1 † Yu

De-Hong

2 † Lin

Meng-Gan

1 † Zhao

Mei

3 4 Zhu

Wen-Jun

1 Lu

Qin

2 Li

Gui-Xiu

5 Wang

Chao

2 Yang

Yi-Fang

1 Qin

Xue-Mei

5 Fang

Chao

2 * Chen

Hong-Zhuan

2 * Yang

Guo-Hong

1 *

1 Department of Traditional Chinese Medicine, Shanghai Institute of Pharmaceutical Industry, Shanghai 200040, China 2 Department of Pharmacology, Institute of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China 3 Department of Pharmacy, Shanghai Institute of Health Sciences, Shanghai 201318, China 4 Department of Pharmacy, Health School Attached to Shanghai Jiao Tong University School of Medicine, Shanghai 201318, China 5 Department of Pharmaceutical Sciences, School of Chemistry, Shanxi University, Taiyuan 030006, China

†

These authors contributed equally to this work.

* Authors to whom correspondence should be addressed; Email: fangchao100@hotmail.com (F.C.); hongzhuan_chen@hotmail.com (H.-Z.C.); ghyang@yahoo.cn (G.-H.Y.); Tel./Fax: +86-21-6467-4721 (F.C. and H.-Z.C.); Tel.: +86-21-6247-9808 (G.-H.Y.); Fax: +86-21-6247-3018 (G.-H.Y.).

13 04 2012

04 2012

17 4 4474 4483 17 02 2012 05 04 2012 06 04 2012

2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Two new polyketides: 2Z-(heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (1) and 2-(heptadec-12-enyl)-5-hydroxy-5,6,7,8-tetrahydrochromen- 4-one (2), together with eleven known compounds: 4-hydroxy-2-[(3,4-methylenedioxy- phenyl)tridecanoyl] cyclohexane-1,3-dione (3), oleiferinone (4), 4-hydroxy-2-[(3,4- methylenedioxyphenyl)undecanoyl]cyclohexane-1,3-dione (5), 4-hydroxy-2-[(11-phenyl- undecanoyl)cyclohexane-1,3-dione (6), proctorione C (7), surinone C (8), 5-hydroxy- 7,8,4'-trimethoxyflavone (9), 5-hydroxy-7,8,3',4'-tetramethoxyflavone (10), 5-hydroxy- 7,3',4'-trimethoxyflavone (11), 5,8-dihydroxy-7,3',4'-trimethoxyflavone (12) and cepharanone B (13) were isolated from the whole plant of Peperomia dindygulensis Miq. Their structures were elucidated by spectroscopic methods, including 2D-NMR techniques. Compounds 2, 3, 5 and 8 inhibited human umbilical vein endothelial cell (HUVEC) proliferation and compounds 5 and 8 sharply suppressed HUVEC tube formation.

Peperomia dindygulensis Miq. polyketides antiangiogenic activity

1. Introduction

Peperomia dindygulensis Miq. (Piperaceae), a widespread herb in the south of China, is used in the folk medicine to treat cough, asthma, phthisis, and stomach, lung, mammary and liver cancers [1]. The common constituents of Peperomia genus include secolignans, tetrahydrofuran lignans, chromones and acylcyclohexane-1,3-diones [2,3,4,5,6,7], which possess various bioactivities, such as antitumor and anti-HIV activities [8]. We found that the chloroform extract prepared from P. dindygulensis showed significant suppression acitivity against the proliferation of primary human umbilical vein endothelial cells (HUVEC). In our previous research, we isolated some antiangiogenic secolignans including two new secolignans from P. dindygulensis [9]. Further fractionation and purification of the CHCl₃ extract led to the isolation and characterization of two new polyketides: 2-(heptadec-12-enyl)-4-hydroxy-3,4,7,8- tetrahydro-2H-chromen-5(6H)-one (1) and 2-(heptadec-12-enyl)-5-hydroxy-5,6,7,8-tetrahydrochromen-4- one (2), together with eleven known compounds: 4-hydroxy-2-[(3,4-methylenedioxyphenyl)tridecanoyl] cyclohexane-1,3-dione (3) [10], oleiferinone (4) [11], 4-hydroxy-2-[(3,4-methylenedioxyphenyl) undecanoyl]cyclohexane-1,3-dione (5) [10], 4-hydroxy-2-[(11-phenylundecanoyl)cyclohexane-1,3-dione (6) [12], proctorione C (7) [13], surinone C (8) [14], 5-hydroxy-7,8,4'-trimethoxyflavone (9) [15], 5-hydroxy-7,8,3',4'-tetramethoxyflavone (10) [16], 5-hydroxy-7,3',4'-trimethoxyflavone (11) [17], 5,8-dihydroxy-7,3',4'-trimethoxyflavone (12) [15] and cepharanone B (13) [18] (Figure 1).

Figure 1

Structures of compounds 1–13.

2. Results and Discussion

Compound 1 was assigned the molecular formula C₂₆H₄₄O₃ from the HRESI-MS m/z 427.3185 [M+Na]⁺ peak (calcd for C₂₆H₄₄O₃Na, 427.3188). The IR spectrum exhibited a hydroxyl absorption at 3,466 cm⁻¹. A long alkyl chain was indicated from the multiple-proton signal in the range δ_H 1.26–1.37 in the ¹H-NMR spectrum (Table 1). Two olefinic signals at δ_C 129.8 and 129.9 in the ¹³C-NMR spectrum (Table 1) suggested the presence of a double bond, and its position at C-12' was further confirmed by EI-MS (Figure 2), HMBC and ¹H-¹H COSY spectra (Figure 3). The cis-geometry of a double bond could be deduced from chemical shifts of C-11' (δ_C 27.2) and C-14' (δ_C 26.9) [19]. Two oxymethine [δ_H 4.00 (1H, dddd, 1.7, 5.4, 7.3,11.2, H-2) and δ_H 4.75 (1H, dd, 7.0, 9.3, H-4)] and five methylenes [δ_H 2.22 (1H, ddd, 2.0, 6.7, 13.5, H-3a) and 1.70 (1H, m, H-3b), δ_H 2.33 (1H, dd, 9.6, 16.8, H-6a) and 2.39 (1H, m, H-6b), δ_H 1.97 (1H, dd, J = 6.3, 12.9, H-7a) and 1.96 (1H, dd, J = 6.1, 12.9, H-7b), δ_H 2.40 (2H, m, H-8), δ_H 1.62 (1H, m, H-1'a) and 1.73 (1H, m, H-1'b)] were found to be connected to two moieties, ⁶CH₂–⁷CH₂–⁸CH₂ and O–⁴CH–³CH₂–²CH(O)–^1'CH₂ using the ¹H–¹H COSY spectrum. The above two moieties were linked by the two quaternary olefinic carbons δ_C 173.4 (C-8a) and 114.7 (C-4a) which showed HMBC cross-peaks with H-4, H-7, H-8, and with H-3, H-8, respectively. The location of carbonyl carbon δ_C 200.6 (C-5) could be confirmed by the HMBC correlations with H-6 and H-7. Thus, the moiety were determined as O=⁵C–⁶CH₂–⁷CH₂–⁸CH₂–^8aC=^4aC–⁴CH(O)–³CH₂–²CH(O)–^1'CH₂ and further confirmed by the homoallylic coupling between H-4 and H-8 in the ¹H-¹H COSY spectrum. The downfield chemical shift of C-8a and the remaining two degrees of unsaturation suggested that the oxygen at C-2 connected to C-8a, and C-5 to C-4a. The 5-hydroxytetrahydrochromen moiety was also confirmed by the mass spectrum which showed a fragment at m/z 167 (Figure 2). Thus, the structure of 1 was elucidated as 2Z-(heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one. The NOE correlation between H-2 and H-4 indicated their cis-configuration.

molecules-17-04474-t001_Table 1

Table 1

¹H- (400 MHz) and ¹³C-NMR (100 MHz) data of compound 1 (in CDCl₃; δ in ppm, J in Hz).

Position	δ_C	δ_H
2	77.1	4.00 (1H, dddd, 1.7, 5.4, 7.3,11.2)
3	35.2	2.22 (1H, ddd,2.0, 6.7, 13.5); 1.70 (1H, m)
4	62.1	4.75 (1H, dd, 7.0, 9.3)
4a	114.7
5	200.6
6	36.7	2.33 (1H, dd, 9.6, 16.8); 2.39 (1H, m)
7	20.5	1.97 (1H, dd, 6.3, 12.9); 1.96 (1H, dd, 6.1, 12.9)
8	28.4	2.40 (2H, m)
8a	173.4
1'	34.7	1.62 (1H, m); 1.73 (1H, m)
2'	25.0	1.46 (2H, m)
3'-10'	29.3–29.8	1.26–1.37 (16H, m)
11'	27.2	2.00 (2H, m)
12', 13'	129.8, 129.9	5.35 (2H, m)
14'	26.9	2.01 (2H, m)
15'	32.0	1.30 (2H, m)
16'	22.4	1.31 (2H, m)
17'	14.0	0.88 (3H, t, 7.0)
OH-4		4.63 ( brs)

Figure 2

MS fragmentation of 1.

Figure 3

Key ¹H-¹H COSY and HMBC correlations of 1.

Compound 2 had the molecular formula C₂₆H₄₂O₃ as deduced from the HRESI-MS peak at m/z 425.3029 [M+Na]⁺ (calcd for C₂₆H₄₂O₃Na, 425.3032). The UV maxima at 249 nm, and the IR absorptions at 1,661, 1,605 cm⁻¹ suggested the presence of a γ-pyrone ring, which was 2,3,5-trisubstituted according to the olefinic signals at δ_C 112.7 (C-3) and δ_H 6.10 (1H, s, H-3) in the NMR spectra (Table 2) [20]. Similar to compound 1, it showed evidence for one moiety, ⁵CH(O)–⁶CH₂–⁷CH₂–⁸CH₂, and a alkyl chain from the ¹H-NMR, ¹³C-NMR, and ¹H-¹H COSY and HMBC spectra (Figure 4). In the HMBC spectrum, the proton of the oxymethylene δ_H 4.91 (1H, br t, J = 3.8 Hz, H-5) showed correlation with the carbonyl carbon (δ_C 180.7), C-4a (δ_C 123.2), C-6 (δ_C 29.5), C-7 (δ_C 18.1) and C-8 (δ_C 27.6), indicating that C-5 is connected with C-4a. The protons of the methylene [δ_H 2.46 (1H, m, H-8a) and 1.98 (1H, m, H-8b)] gave cross peaks with the carbons at C-5, C-6, C-7, C-4a and C-8a, but not with C-4, suggesting that C-8 is attached to C-8a. Surprisingly, the weak four bond reciprocal H-5/C-8 and H-8/C-5 HMBC correlations signals were observed. Although these may be considered unusual, such long-range correlations have been reported, especially in constrained ring systems [21,22,23]. The HMBC spectrum also suggested the linkage of C-2 and the alkyl chain. Thus, the structure of 2 was determined to be 2-(heptadec-12-enyl)-5-hydroxy-5,6,7,8- tetrahydrochromen-4-one.

molecules-17-04474-t002_Table 2

Table 2

¹H- (400 MHz) and ¹³C-NMR (100 MHz) data of compound 2 (in CDCl₃; δ in ppm, J in Hz).

Position	δ_C	δ_H
2	169.3
3	112.7	6.10 (1H, s)
4	180.7
4a	123.2
5	63.8	4.91 (1H, br t, 3.8)
6	29.5	1.76 (1H, m); 1.96 (1H, m)
7	18.1	1.74 (1H, m); 1.97 (1H, m)
8	27.6	2.49 (1H, m); 2.57 (1H, m)
8a	165.0
1'	33.5	2.48 (2H, t, 7.6)
2'	26.8	1.61 (2H, m)
3'–10'	28.9–29.7	1.26–1.37 (16H, m)
11'	27.1	2.00 (2H, m)
12', 13'	129.8	5.35 (2H, m)
14'	26.9	2.01 (2H, m)
15'	31.9	1.30 (2H, m)
16'	22.3	1.31 (2H, m)
17'	14.0	0.89 (3H, t, 6.4)
5-OH		4.43 ( brs)

Figure 4

Key ¹H-¹H COSY and HMBC correlations of 2.

The structures of known compounds 3~13 were confirmed by detailed NMR and MS data comparison with those in the literature [10,11,12,13,14,15,16,17,18]. In addition, some similar compounds have been reported from Trichoderma [24,25].

In vitro cytotoxicity of all the isolated compounds to HUVEC was examined after 48 h incubation. It was found that compounds 2, 3, 5, 8 could dose dependently induced significant toxicity to HUVEC at different concentrations (Figure 5). The growth of HUVEC was almost completely inhibited by compound 3 at 24 μM. Compounds 5 and 8 also exhibited significant tube formation-inhibiting activity at 3, 6, 12 and 24 μM, respectively (Figure 6).

Figure 5

Effect of compounds 2 (A), 3 (B), 5 (C), 8 (D) on the viability of HUVEC after 48 h incubation. For blank control, the DMSO concentration was adjusted to below 0.1%. Values are expressed as mean ± SD, n = 4–6. * p < 0.05, ** p < 0.01 as compared with control.

Figure 6

Effect of compounds 5, compound 8, and ursolic acid on HUVEC tube formation. A, B, and C: Tube length (% of control) after treatment with compound 5, compound 8, and ursolic acid (positive control), respectively. Values are expressed as mean ± SD, n = 4. * p < 0.05, ** p < 0.01 as compared with control. (D): The representative photographs of tube networks after treatment with ursolic acid (10 μM) and compounds 5 and 8 at various concentrations. Bar = 200 μm.

3. Experimental 3.1. General

Optical rotations were measured on a Perkin-Elmer 341 polarimeter. UV spectra were recorded on a Shimadzu UV-2500 PC spectrophotometer. IR spectra were recorded on a Nexus 670 spectrometer. NMR spectra were measured on a Bruker DRX 400 spectrometer and Bruker AV 500 spectrometer. EI-MS (70 eV) was carried out on an Autospec Premier P708 mass spectrometer. ESI-MS was carried out on a Waters Q-Tof micro YA019 mass spectrometer. Silica gel (200–300 mesh) was used for column chromatography, and pre-coated silica gel GF254 plates (Qingdao Marin Chemical Plant, Qingdao, China) were used for TLC.

3.2. Plant Material

Peperomia dindygulensis Miq., collected in Simao Region Yunnan Province of China in June 2008, was identified by Associate Professor Guo-Hong Yang. A voucher specimen (GHY-PDM20080728) has been deposited in the Herbarium of the Laboratory of Department of Traditional Chinese Medicine, Shanghai Institute of Pharmaceutical Industry, China.

3.3. Extraction and Isolation

The air-dried whole plant (10 kg) of P. dindygulensis was extracted exhaustively with 95% EtOH at r.t. (250 L, 7 days). The EtOH extract was evaporated in vacuo to yield a semisolid (1,300 g), of which 1,290 g was suspended in H₂O (2,000 mL) and partitioned with CHCl₃ (2,000 mL × 5) to yield 756 g of extract after concentration. Part of the CHCl₃ extract (300 g) was subjected to column chromatography on Si gel (200~300 mesh, 3 kg) eluted with petroleum ether/EtOAc (100:0, 99:1, 49:1, 19:1, 9:1, 4:1, 7:3, 3:2, 1:1) and EtOAc to yield ten fractions (Frs. 1–10). Fraction 6 (13.9 g) was separated repeatedly on silica gel columns (5 × 50 cm) using n-hexane/acetone (5:1) as eluent to obtain six fractions (6A–F). Fraction 6B (227 mg) was further purified by Sephadex LH-20 and eluted with CHCl₃/MeOH (1:1) to give 1 (10 mg). Fraction 6D (139 mg) was purified repeatedly by Sephadex LH-20 using CHCl₃/MeOH (1:1) as eluent to give 3 (20 mg). Fraction 7 (21.8 g) was separated repeatedly on silica gel columns (5 × 50 cm) using n-hexane/acetone (4:1) as eluent to obtain five fractions (7A–E). Fraction 7B (1.6 g) was further purified by Sephadex LH-20 [eluted with CHCl₃/MeOH (1:1)] to give four fractions, and the second fraction (700 mg) was applied to preparative silica gel TLC using n-hexane/acetone/acetic acid (5:1:0.1) as eluent to afford 4 (40 mg), 5 (100 mg) and 6 (12 mg). Fraction 7C (7.6 g) was chromatographed over silica gel columns (3 × 50 cm) and eluted with n-hexane/EtOAc (3:1) to obtain five fractions, the second fraction (154 mg) was applied to preparative silica gel TLC using toluene/EtOAc (9:1) as eluent to give 11 (4 mg). Fraction 8 (4.5 g) was chromatographed over silica gel columns (3 × 50 cm) eluted with CHCl₃/MeOH (50:1) to obtain four fractions (8A–D). Fraction 8B (205 mg) was recrystallized from CHCl₃/MeOH (1:1) to afford 9 (51 mg). Fraction 8C (600 mg) was recrystallized from CHCl₃/MeOH (1:1) to afford 10 (246 mg). Fraction 8D (1.4 g) was chromatographed over silica gel columns (3 × 50 cm) and eluted with n-hexane/acetone/acetic acid (100:10:1) to give 2 (277 mg) and 6 (36 mg). Fraction 9 (18.9 g) was separated repeatedly on silica gel columns (5 × 50 cm) using n-hexane/acetone (4:1) as eluent to obtain eight fractions (9A–H). Fraction 9B (1.5 g) was further separated repeatedly on silica columns (3 × 50 cm) and eluted with CHCl₃/acetone (200:1) to give three fractions, and the second fraction was subjected to preparative silica gel TLC using n-hexane/acetone/acetic acid (100:10:1) as eluent to give 8 (20 mg). Fraction 9D (1.8 g) was chromatographed on silica gel columns (3 × 50 cm) using n-hexane/acetone (5:1) as eluent to obtain three fractions, and the last fraction (222 mg) was further purified by Sephadex LH-20 and eluted with CHCl₃/MeOH (1:1) to give 13 (5 mg). Fraction 9E (12.2 g) was separated repeatedly on silica gel columns (5 × 50 cm) using CHCl₃ as eluent to obtain six fractions, and the last fraction was separated repeatedly by Sephadex LH-20 and eluted with CHCl₃/MeOH (1:1) to give 12 (12 mg).

2Z-(Heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (1). Yellowish oil; [α]_D¹³ 126° (c = 0.368, CHCl₃); UV λ_max (MeOH) nm (log ε): 258 (4.44); IR (NaCl) ν_max: 3466, 2925, 2854, 1613, 1427, 1370, 1249, 1188, 1083, 1054 cm⁻¹; EI-MS m/z 404 [M]⁺ (9.1), 386 (100.0), 167 (24.1), 139 (50.7), 125 (43.1), 111(41.9), 97 (5.2), 43 (21.5); ¹H- and ¹³C-NMR data: see Table 1; HRESI-MS m/z 427.3185([M+Na]⁺, calcd for C₂₆H₄₄O₃Na 427.3188).

2-(Heptadec-12-enyl)-5-hydroxy-5,6,7,8-tetrahydrochromen-4-one (2). Yellowish oil; [α]_D¹³ 34° (c = 0.435, CHCl₃); UV λ_max (MeOH) nm (log ε): 216 (3.66), 249 (3.68); IR(NaCl) ν_max: 3431, 3003, 2926, 2854, 1716, 1661, 1605, 1436, 1176, 1086, 950, 859, 722 cm⁻¹; ¹H- and ¹³C-NMR data: see Table 2; HRESI-MS m/z 425.3029 ([M+Na]⁺, calcd for C₂₆H₄₂O₃Na 425.3032).

3.4. Antiangiogenic Activity Assays

The effect of isolated compounds on the proliferation of HUVEC was evaluated by CCK-8. HUVEC tube formation was conducted for the assay of in vitro angiogenesis using the Chemicon in vitro angiogenesis assay kit (ECM625). Details of the assays were provided in a previous report [9].

4. Conclusions

Two new polyketides: 2Z-(heptadec-12-enyl)-4-hydroxy-3,4,7,8-tetrahydro-2H-chromen-5(6H)-one (1), and 2-(heptadec-12-enyl)-5-hydroxy-5,6,7,8-tetrahydrochromen-4-one (2), were isolated from Peperomia dindygulensis, together with eleven known compounds 3–13. Compounds 2, 3, 5 and 8 inhibited human umbilical vein endothelial cells (HUVEC) proliferation and compounds 5 and 8 sharply suppressed HUVEC tube formation.

Acknowledgments

This work was financially supported by State Innovative Drugs Science and Technology Major Projects of China (No. 2009ZX09301-007), National Natural Science Foundation of China (No. 30600788, 30873179, 30901852), Shanghai Rising-Star Program (No. 09QA1403500, 10QB1404000), Innovation Program of Shanghai Municipal Education Commission (No. 12zz200), and “Chen Guang” project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (No. 107GB03).

References and Notes 1. Editorial Board of China Herbal State Administration of Traditional Chinese Medicine, China China Herbal Shanghai Scientific and Technical Publishers

Shanghai, China

1999 421 2.

Govindachari

T.R.

Kumari

K.G.N.

Partho

P.D.

Two secolignans from Peperomia dindigulensis

Phytochemistry 1998 49 2129 2131

10.1016/S0031-9422(98)00393-8

J.L.

Hasegawa

Sakai

Kakuta

Tang

Oka

Kiuchi

Ogura

Kataoka

Bioactive tetrahydrofuran lignans from Peperomia dindygulensis

J. Nat. Prod. 2005 68 1656 1660

10.1021/np050283e

16309318

J.L.

Hasegawa

Sakai

Mitsui

Ogura

Kataoka

Oka

Kiuchi

Tomida

Bioactive dibenzylbutyrolactone and dibenzylbutanediol lignans from Peperomia duclouxii

J. Nat. Prod. 2006 69 790 794

10.1021/np0600447

Ning

M.M.

Zhou

C.H.

Yang

Q.R.

Wang

M.W.

Bioactive compounds from Peperomia pellucida

J. Nat. Prod. 2006 69 247 250

10.1021/np050457s

Monache

F.D.

Compagnone

R.S.

A secolignan from Peperomia glabella

Phytochemistry 1996 43 1097 1098

10.1016/S0031-9422(96)00449-9

Mbah

J.A.

Tchuendem

M.H.K.

Tane

Sterner

Two chromones from Peperomia vulcanica

Phytochemistry 2002 60 799 801

10.1016/S0031-9422(02)00191-7

12150802

Zhang

G.L.

Wang

Y.H.

Zheng

Y.T.

Zhang

Wang

M.W.

Bioactive lignans from Peperomia heyneana

J. Nat. Prod. 2007 70 662 664

10.1021/np0605236

17291043

9. Lin

M.G.

D.H.

Wang

Q.W.

Zhu

W.J.

Bai

G.X.

Wang

X.W.

Yang

Y.F.

Qin

X.M.

Secolignans with antiangiogenic activities from Peperomia dindygulensis

Chem. Biodiv. 2011 8 862 871

10.1002/cbdv.201000123

10.

J.L.

Hasegawa

Sakai

Bai

L.M.

Wang

L.Y.

Kakuta

Furuya

Ogura

Kataoka

Bioactive polyketides from Peperomia duclouxii

J. Nat. Prod. 2007 70 998 1001

10.1021/np070089n

11.

Azevedo

N.R.

Santos

S.C.

De Miranda

E.G.

Ferri

P.H.

A 2-Acylcyclohexane-1,3-dione from virola oleifera

Phytochemistry 1997 46 1375 1377

10.1016/S0031-9422(97)00503-7

12.

Kato

M.J.

Lopes

X.L.M.

Paulino Fo

H.F.

Yoshida

Gottlieb

O.R.

Acylresorcinols from Virola sebifera and Virola elongate

Phytochemistry 1985 24 533 536

10.1016/S0031-9422(00)80762-1

13.

Seeram

N.P.

Lewis

Jacobs

Nair

M.G.

McLean

Reynolds

W.F.

Proctoriones A–C: 2-Acylcyclohexane-1,3-dione derivatives from Peperomia proctorii

J. Nat. Prod. 2000 63 399 402

10.1021/np990447p

14.

Cheng

M.J.

Lee

S.J.

Chang

Y.Y.

S.H.

Tsai

I.L.

Jayaprakasam

Chen

I.S.

Chemical and cytotoxic constituents from Peperomia sui

Phytochemistry 2003 63 603 608

10.1016/S0031-9422(03)00183-3

12809722

15.

Chu

H.W.

H.T.

Lee

Y.J.

Regioselective hydroxylation of 2-hydroxychalcones by dimethyldioxirane towards polymethoxylated flavonoids

Tetrahedron 2004 60 2647 2655

10.1016/j.tet.2004.01.023

16.

Shaw

S.C.

Azad

Mandal

S.P.

Gandhi

R.S.

Synthesis of 6-hydroxyluteolin and sinensetin by wessely-Moser rearrangement

J. Indian Chem. Soc. 1988 LXV 107 109 17.

Tang

H.L.

Y.L.

Zhang

W.D.

Flavonoids from rhizomes of Veratum dahuricum

Chem. Nat. Compd. 2007 43 696 697

10.1007/s10600-007-0233-8

18.

Araújo

J.X.

Chaves

M.C.O.

Da Cunha

E.V.L.

Gray

A.I.

Cepharanone B from Piper tuberculatum

Biochem. Syst. Ecol. 1999 27 325 327

10.1016/S0305-1978(98)00083-0

19.

Mizutani

Fuknaga

Tanaka

Takasugi

Saruwatari

Y.I.

Fuwa

Yamauchi

Wang

Jia

M.R.

F.Y.

Amides from Huajiao, Pericarps of Zanthoxylum bungeanum maxim

Chem. Pharm. Bull. 1988 36 2362 2365

10.1248/cpb.36.2362

20.

Yoshii

Koizumi

Oribe

The structure of agarotetrol, a novel highly oxygenated chromone from agarwood (jinko)

Tetrahedron Lett. 1978 41 3921 3924 21.

El-Elimat

Qandil

Alkofahi

Tawaha

Burgess

J.P.

Nakanishi

Kroll

D.J.

Navarro

H.A.

New colchicinoids from a native Jordanian meadow saffron, Colchicum brachyphyllum: Isolation of the first naturally occurring dextrorotatory colchicinoid

J. Nat. Prod. 2005 68 173 178

10.1021/np0496587

22.

Isaka

Palasarn

Auncharoen

Kornmijit

Jones

E.B.G.

Acremoxanthones A and B, novel antibiotic polyketides from the fungus Acremonium sp. BCC 31806

Tetrahedron Lett. 2009 50 284 287

10.1016/j.tetlet.2008.10.146

23.

Liu

Y.B.

Mulabagal

Bowen-Forbes

C.S.

Aviayan

Nair

M.G.

Inhibition of lipid peroxidation, cyclooxygenase enzyme and human tumor cell proliferation by compounds in herbal water

Mol. Nutr. Food Res. 2009 53 1177 1186

10.1002/mnfr.200800545

19653224

24.

Dunlop

R.W.

Simon

Sivasithamparam

Ghisalberti

E.L.

An antibiotic from Trichoderma koningii active against soilborne plant pathogens

J. Nat. Prod. 1989 52 67 74

10.1021/np50061a008

25.

Cutler

H.G.

Himmelsbach

D.S.

Yagen

Arrendale

R.F.

Jacyno

J.M.

Cole

P.D.

Cox

R.H.

Koninginin B: A biologically active congener of koninginin A from Trichoderma koningii

J. Agric. Food Chem. 1991 39 977 980

10.1021/jf00005a035

Sample Availability: Not available.